We are live on ! Find out more
MGB

Mass General Brigham Portfolio holdings

AUM $361M
This Fund
S&P 500
This Quarter Est. Return
+26.07%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$43.6M
AUM Growth
+$23.1M
Cap. Flow
+$18.2M
Cap. Flow %
41.69%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
IOT icon
Samsara
IOT
+$18.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 50.5%
2 Technology 49.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOT icon
1
Samsara
IOT
$22.9B
$21.6M 49.5%
+448,753
New +$18.2M
RVMD icon
2
Revolution Medicines
RVMD
$44B
$15.3M 35.15%
338,191
PLRX icon
3
Pliant Therapeutics
PLRX
$66.3M
$3.24M 7.42%
288,690
TNGX icon
4
Tango Therapeutics
TNGX
$4.31B
$2.73M 6.25%
354,192
FULC icon
5
Fulcrum Therapeutics
FULC
$284M
$733K 1.68%
205,356

Similar funds

Mass General Brigham's Q3 2024 Portfolio in Review

As of Q3 2024, Mass General Brigham held 5 positions worth $43.6M, up 112% from $20.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Mass General Brigham deployed $18.2M of net new capital in Q3 2024, opening 1 new position. Its largest new stake was Samsara: 448,753 shares worth $21.6M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 100% a quarter earlier, followed by Technology.

  • Mass General Brigham's largest Q3 2024 buy was Samsara: 448,753 shares worth $21.6M.
  • Mass General Brigham's ten largest holdings make up 100% of its $43.6M portfolio in Q3 2024.
  • Mass General Brigham opened 1 new position and closed 0 in Q3 2024.
  • Mass General Brigham's portfolio value rose 112% quarter-over-quarter to $43.6M.

Based on Mass General Brigham's 13F filing for Q3 2024, filed 16 Oct 2024.